Antibiotice Iasi Sales up 54% to RON248M in H1

08.18.2022 By Georgiana Mihalache

Romanian pharmaceutical manufacturer Antibiotice (ATB.RO) Iasi’s total revenue from sales reached RON248.1 million in the first half of 2022, up 54% on the RON161.4 million in the year-ago period, the company said in its report to the Bucharest Stock Exchange.

To read the full story, please login. Not a member? Subscribe here.

Reveal Romania! Business news & views.
Find out all you need by reading the entire story
To invest in Romania, you need to find out about its opportunities.
To close a strategic partnership with a Romanian company, you need to learn about its market position and whether it is a trustworthy partner
To grow here, you need to be informed

Subscribe now
Only 50 euros/month (VAT not included)
Get access to reports, news and statistics in the main sectors of Romania’s economy. Follow the strategic moves of companies operating in Romania. We will keep you updated on the latest business events.
Contact: E: newsroom@zfenglish.com (newsroom), marketing@zfenglish.com (Marketing & PR), sales@zfenglish.com (subscriptions)
T: 0040-318.256.431 (Newsroom)
0040-318.256.158, 0040-318.256.408 (Subscriptions Department)
0040-318.256.469, 0040-318.256.470 (Advertising Sales Department)
0040-318.256.427, 0040-318.256.129 (Marketing & PR)

LOGIN / Lost password?

Keywords:
antibiotice
, sales
, growth

Please fill all required fields!

Your comment was successfully added!

Comments will appear only after the moderation.